FeesSafety
Pluang+

dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.

Company Fundamentals
04 Nov 2026, 13:00 WIB
Na
View Source
Bullish
dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.

dsm-firmenich announced a strong Q3 2026 trading update with 5% like-for-like sales growth and an improved Adjusted EBITDA margin of 20.4%. The company’s performance was driven by volume growth across its three business units: Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. The firm raised its full-year 2026 sales growth outlook to around 5%, up from the previous 2-4% range, and confirmed its 2026-2028 action plan is on track. Cost-saving initiatives and restructuring efforts are progressing well, supporting margin expansion and cash discipline going forward.

dsm-firmenich Q3 2026 trading update provides context for readers. For those watching Consumer Staples, 18 of 63 US stocks rose and 43 fell on Pluang. Dollar General Corp. (DG) dropped 3.85% to USD 130.55, Krispy Kreme Inc (DNUT) fell 3.83% to USD 3.26 with 100% sell orders, and Anheuser-Busch Inbev SA (BUD) declined 3.47% to USD 81.06. Data is as of Nov 04, 2026, 13:11 WIB.

More News

STMicroelectronics launches unified STM32 MCU platform for industrial, automotive, and AI applications.

STMicroelectronics launches unified STM32 MCU platform for industrial, automotive, and AI applications.

STMicroelectronics announced a unified STM32 microcontroller platform that spans industrial, automotive, and robotics applications, enabling developers to reuse architectures, software, and tools across these sectors. The new STM32A family extends th...

Market News
Bullish
11 minutes ago
Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.

Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.

Solvay's Q3 2026 underlying net sales fell 3.3% organically to €1,031 million, impacted by the Middle East conflict and weak soda ash markets. EBITDA dropped 26.6% organically to €173 million, partly due to a €25 million impact from the conflict and ...

Company Fundamentals
Bearish
11 minutes ago
Milestone Pharmaceuticals grants 33,000 stock options to new employee under Nasdaq inducement rule.

Milestone Pharmaceuticals grants 33,000 stock options to new employee under Nasdaq inducement rule.

Milestone Pharmaceuticals announced the grant of 33,000 stock options to a newly hired employee as an inducement under Nasdaq Listing Rule 5635(c)(4). The options, priced at $0.72 each, will vest over four years with a one-year cliff and monthly inst...

Company Fundamentals
Neutral
4 hours ago
XRP whales increase holdings amid stable $1.20-$1.25 price range, signaling potential accumulation phase.

XRP whales increase holdings amid stable $1.20-$1.25 price range, signaling potential accumulation phase.

The number of XRP wallets holding at least 1 million tokens has reached a 2026 high of 2,147, according to Santiment. This increase in large holders occurred while XRP traded in a narrow $1.20 to $1.25 range, suggesting accumulation by long-term inve...

Protocol Fundamentals
Bullish
5 hours ago
Democrat Troy Jackson wins Maine Senate seat, flipping it from Republican control after nearly 30 years.

Democrat Troy Jackson wins Maine Senate seat, flipping it from Republican control after nearly 30 years.

Troy Jackson, the Democratic candidate, narrowly defeated incumbent Republican Senator Susan Collins in Maine, marking a significant political shift. Collins had held the seat since 1997, but Jackson's win by just over 2,000 votes flips the seat to t...

Market News
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App